Lilly Launches New Award To Promote Enlightened Oncology Reporting
02 June 2006 - 10:00PM
PR Newswire (US)
Luminous Award to recognize and reward outstanding cancer reporting
around the world ATLANTA, June 2 /PRNewswire-FirstCall/ -- Lilly
Oncology today launched a new initiative to encourage "enlightened,
intelligent and inspiring" journalism on cancer-related issues
around the world. The Luminous Award, announced today at the
American Society of Clinical Oncology (ASCO) annual meeting, will
recognize and reward journalism that enlightens audiences by
providing responsible, accurate and timely information on advances
in cancer prevention and treatment. The Luminous Award is open to
all journalists -- staff or freelance -- writing for national or
local newspapers, magazines, newsletters or websites, specialist
health/medical publications and business or pharmaceutical trade
publications. There will also be a separate category for broadcast
journalists. "We are delighted to present this important award,"
said Garry Nicholson, Lilly Oncology platform leader. "By helping
to enlighten people affected by cancer -- either directly or
indirectly -- we will be fulfilling one of our major commitments as
a company, namely to provide support in its broadest sense to
people with cancer and their families." The prestigious independent
judging panel will consist of leading cancer specialists from
around the world, representatives of professional oncology
organizations and patient advocacy groups. The panel will nominate
award winners based on a range of criteria including news value;
raising awareness of advances in oncology; timeliness, clarity and
accuracy in describing the science behind the story; and creativity
of approach. The independent judging panel will be the sole
decision maker during the judging process and its selection of the
winners will be final. The winner of the Luminous Award will have
the opportunity to choose a seven-day trip to Boston, London, New
York, Paris or Sydney for two. In addition the winner will meet
with a world-renowned oncologist or cancer researcher, based in the
chosen city, who will enlighten him or her about their current
research, discuss exciting new advances and answer any questions
the winner may have. In lieu of the trip, the winner can choose for
Eli Lilly and Company to donate a euro 10,000 scholarship in the
winner's name to a well respected academic institution with a
journalism program. The goal of the scholarship is to inspire a
student to learn the skills of clear, accurate and intelligent
reporting. There will also be a runner-up prize of five days of
enlightenment for two to either London or New York where he or she
will have the opportunity to meet with a world-renowned oncologist
or cancer researcher who will share their insights. In lieu of the
five-day trip, the runner-up can choose for Eli Lilly and Company
to donate a euro 5,000 scholarship in his or her name, to a well
respected academic institution with a journalism program. Articles
for submission should be between 1,000 and 3,000 words in length
and, if not written in English, accompanied by a one to two
paragraph summary in English. All articles must be the original
work of the entrant, and have been published between 1 September
2001 and 30 August 2006. Deadline for entries is 1 September 2006.
Certain local restrictions may apply regarding this journalism
award and the award is only available where not prohibited or
restricted by local laws and regulations. O-LLY For further
information and an entry form, please contact the Luminous Award
Secretariat Katie Fyfe on: Tel: +44 207 395 7100 Fax: +44 207 395
7101 E-mail: (Logo:
http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )
http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO DATASOURCE:
Eli Lilly and Company CONTACT: Christine Van Marter of Eli Lilly
and Company, +1-317-651-1473,
Copyright